XOPIXOL LA 200MG/1ML Injection by Genetics Pharma contains Zuclopenthixol Decanoate 200mg/1mL, a long-acting depot antipsychotic injection used for the maintenance treatment of certain psychotic disorders, particularly schizophrenia.
Unlike conventional oral antipsychotic tablets that need to be taken every day, a long-acting depot injection is administered by a healthcare professional at intervals determined by the prescribing doctor. This approach can help maintain therapeutic medicine levels over time and may be useful for patients who require ongoing antipsychotic treatment and have difficulty taking daily medication consistently.
Zuclopenthixol is a thioxanthene antipsychotic that primarily works by blocking dopamine receptors in the brain. By reducing excessive dopaminergic activity, it can help control symptoms such as hallucinations, delusions, severe agitation, and other psychotic symptoms.
XOPIXOL LA 200MG/1ML INJECTION is an alternative to CLOPIXOL Depot 200MG/1ML Injection.
⚠️ CLOPIXOL Depot 200MG/1ML Injection has been discontinued and is no longer the currently available product in this listing.
➡️ CLOPIXOL Depot 200MG/1ML Injection → DISCONTINUED
➡️ XOPIXOL LA 200MG/1ML Injection → CURRENT ALTERNATIVE
Both products contain the same active ingredient, Zuclopenthixol Decanoate, but patients should not switch between depot injections on their own. The prescribing psychiatrist or healthcare professional should confirm the appropriate product, dose, injection interval, and treatment plan.
Now available from SuperCare Pharma, providing genuine pharmaceutical products and convenient access to medicines across Pakistan.
If you are searching for CLOPIXOL Depot 200MG/1ML Injection, please note that this product has been discontinued for this listing.
❌ CLOPIXOL Depot 200MG/1ML Injection – DISCONTINUED
✅ XOPIXOL LA 200MG/1ML Injection
Zuclopenthixol Decanoate
200mg/1mL
XOPIXOL LA provides the same active medicinal ingredient as the discontinued CLOPIXOL Depot product. However, because depot antipsychotic treatment requires individualized dosing and monitoring, your doctor or psychiatrist should confirm the appropriate replacement before administration.
XOPIXOL LA 200MG/1ML Injection is a long-acting intramuscular antipsychotic preparation containing Zuclopenthixol Decanoate 200mg per 1mL.
It is designed to release the active medicine gradually after intramuscular administration, providing prolonged antipsychotic activity.
XOPIXOL LA may be prescribed as maintenance treatment for adults with psychotic disorders such as:
The exact indication, dose, and injection frequency must be determined by a psychiatrist or other qualified healthcare professional.
The depot formulation is designed to release Zuclopenthixol gradually, providing sustained treatment over time.
May help control symptoms associated with psychotic disorders, including hallucinations, delusions, agitation, and disorganized thinking.
Can be used as part of a long-term treatment strategy for patients requiring ongoing antipsychotic medication.
Unlike daily oral medication, the injection is administered at intervals determined by the treating healthcare professional.
Long-acting injectable treatment can help reduce problems associated with missed daily oral doses in appropriately selected patients.
XOPIXOL LA 200MG/1ML contains the same active ingredient, Zuclopenthixol Decanoate, as CLOPIXOL Depot 200MG/1ML.
The active ingredient in XOPIXOL LA is Zuclopenthixol Decanoate.
Zuclopenthixol is an antipsychotic medicine that primarily produces its therapeutic effect through dopamine D2 receptor antagonism in the central nervous system.
Excessive dopamine activity in certain pathways of the brain is associated with psychotic symptoms. By reducing dopamine receptor stimulation, Zuclopenthixol can help decrease symptoms such as:
Because XOPIXOL LA is formulated as a decanoate depot injection, the medicine is released gradually following intramuscular administration rather than being absorbed and eliminated as quickly as a conventional immediate-release medicine.
A psychiatrist may prescribe XOPIXOL LA as part of the maintenance treatment of:
Schizophrenia can cause symptoms including hallucinations, delusions, disorganized thinking, social withdrawal, and changes in behavior.
Long-acting antipsychotic therapy may be considered for selected patients who require ongoing treatment.
Depot formulations can be useful when consistent long-term medication exposure is an important part of the treatment plan.
| Ingredient | Strength | Purpose |
|---|---|---|
| Zuclopenthixol Decanoate | 200mg/1mL | Long-acting antipsychotic used for maintenance treatment of psychotic disorders |
Product: XOPIXOL LA 200MG/1ML Injection
Brand: Genetics Pharma
Dosage Form: Injection
Route: Intramuscular injection
Pack Information: 1 injection
| Product | Active Ingredient | Strength | Current Listing Status |
|---|---|---|---|
| XOPIXOL LA 200MG/1ML Injection | Zuclopenthixol Decanoate | 200mg/1mL | ✅ Available Alternative |
| CLOPIXOL Depot 200MG/1ML Injection | Zuclopenthixol Decanoate | 200mg/1mL | ❌ Discontinued |
Although both products contain Zuclopenthixol Decanoate, do not assume that changing from one depot product to another automatically means the same injection schedule is appropriate.
A psychiatrist or qualified healthcare professional must confirm the replacement, dose, and injection interval.
XOPIXOL LA is a depot intramuscular injection and should be administered only by a trained healthcare professional.
It should not be self-injected.
The doctor determines:
The injection is generally administered deep into a suitable muscle according to professional administration guidelines.
The dosage of Zuclopenthixol Decanoate varies considerably between patients.
Factors that may influence the prescribed dose and injection interval include:
Do not use the 200mg/1mL strength as a standard dose without a doctor's prescription.
The fact that the product contains 200mg per 1mL does not mean every patient should receive the entire ampoule at every visit.
Depot antipsychotics remain in the body for an extended period. Therefore, changing the injection date, dose, or frequency without medical supervision can potentially cause problems.
If you previously received CLOPIXOL Depot 200MG/1ML, contact your psychiatrist or healthcare provider before receiving XOPIXOL LA.
Your healthcare professional should confirm:
✅ The replacement product
✅ Appropriate dose
✅ Injection interval
✅ Previous treatment history
✅ Any required monitoring
Like other antipsychotic medicines, XOPIXOL LA can cause side effects.
Common or possible effects may include:
Some patients may experience extrapyramidal symptoms (EPS), including:
Inform your doctor if these symptoms develop.
Contact a healthcare professional urgently if you experience:
A rare but serious reaction known as neuroleptic malignant syndrome (NMS) can occur with antipsychotic medicines and requires urgent medical attention.
Before receiving XOPIXOL LA, tell your doctor if you have:
Your doctor should know about your complete medical history before prescribing a depot antipsychotic.
XOPIXOL LA may cause drowsiness, dizziness, reduced alertness, or impaired coordination, particularly when treatment begins or the dose changes.
Avoid driving or operating machinery until your doctor confirms that the medicine does not impair your ability to do so safely.
Alcohol may increase drowsiness and other central nervous system effects associated with antipsychotic medicines.
It is generally advisable to avoid alcohol while receiving XOPIXOL LA unless your healthcare professional tells you otherwise.
Tell your doctor about every medicine, supplement, or herbal product you use.
Important potential interactions may involve:
Your doctor will assess potential interactions before treatment.
If you are pregnant, planning to become pregnant, or breastfeeding, inform your doctor before receiving XOPIXOL LA.
Antipsychotic treatment during pregnancy requires individualized medical assessment. Do not stop an established antipsychotic treatment suddenly without discussing it with your healthcare professional.
Older adults may be more sensitive to certain adverse effects of antipsychotic medicines.
The use of antipsychotics in elderly patients with dementia-related psychosis requires particular caution because antipsychotic medicines may be associated with increased risks in this population.
Always follow specialist medical advice.
XOPIXOL LA should be stored according to the manufacturer's instructions.
Generally:
Healthcare professionals should follow the manufacturer's storage and handling requirements.
At SuperCare Pharma, we focus on providing customers with genuine pharmaceutical products and dependable online pharmacy service.
✔ Genuine Pharmaceutical Products
✔ Authentic Getz/Genetics Pharma Products as Listed
✔ Secure Online Ordering
✔ Competitive Prices
✔ Fast Nationwide Delivery Across Pakistan
✔ Carefully Packed Orders
✔ Customer Support for Product Queries
For prescription and depot antipsychotic medicines, always provide a valid prescription and follow your psychiatrist's instructions.
| Product Information | Details |
|---|---|
| Brand | Genetics Pharma |
| Product Name | XOPIXOL LA 200MG/1ML Injection |
| Generic | Zuclopenthixol Decanoate |
| Strength | 200mg/1mL |
| Dosage Form | Injection |
| Route | Intramuscular |
| Pack Size | 1 |
| Category | Antipsychotic / Neurological & Psychiatric Medicine |
| Previous Alternative | CLOPIXOL Depot 200MG/1ML |
| CLOPIXOL Depot Status | Discontinued |
| Current Alternative | XOPIXOL LA 200MG/1ML |
XOPIXOL LA contains Zuclopenthixol Decanoate, a long-acting antipsychotic used mainly for maintenance treatment of schizophrenia and certain other psychotic disorders.
The active ingredient is Zuclopenthixol Decanoate 200mg/1mL.
Yes. XOPIXOL LA is a long-acting depot intramuscular injection designed to release Zuclopenthixol gradually.
Yes. XOPIXOL LA 200MG/1ML Injection is listed as an alternative to CLOPIXOL Depot 200MG/1ML Injection.
Yes. CLOPIXOL Depot 200MG/1ML Injection is discontinued for this product listing. XOPIXOL LA 200MG/1ML is the available alternative listed here.
Yes. Both contain Zuclopenthixol Decanoate, although patients should have their treatment transition confirmed by their prescribing healthcare professional.
No. Depot antipsychotic medicines require individualized dosing and injection schedules. Your psychiatrist or healthcare professional should approve and manage the switch.
It is administered as a deep intramuscular injection by a trained healthcare professional. It should not be self-administered.
Yes. Zuclopenthixol Decanoate is used as a maintenance antipsychotic treatment for schizophrenia and other psychotic disorders when clinically appropriate.
No. It helps control and manage psychotic symptoms but does not cure schizophrenia. Long-term treatment plans should be supervised by a psychiatrist.
Yes. Drowsiness can occur. Patients should avoid driving or operating machinery until they know how the medicine affects them.
Alcohol may increase drowsiness and other effects. It is generally advisable to avoid alcohol and discuss alcohol use with your healthcare provider.
XOPIXOL LA 200MG/1ML Injection is available through SuperCare Pharma, subject to prescription and stock availability.
If you are searching for:
“CLOPIXOL Depot 200MG/1ML”
“CLOPIXOL Depot 200mg injection”
“Zuclopenthixol Decanoate 200mg/1ml”
please note that CLOPIXOL Depot 200MG/1ML is discontinued in this product range/listing.
Generic: Zuclopenthixol Decanoate
Strength: 200mg/1mL
Manufacturer: Genetics Pharma
Important: The alternative should only be used after confirmation by the patient's psychiatrist or prescribing healthcare professional.
If you previously used CLOPIXOL Depot 200MG/1ML Injection, XOPIXOL LA 200MG/1ML Injection provides an alternative containing Zuclopenthixol Decanoate.
For safe treatment, do not change your depot injection without medical advice. Your psychiatrist should confirm the appropriate dose and administration schedule.
Order XOPIXOL LA 200MG/1ML Injection from SuperCare Pharma for genuine pharmaceutical products, secure ordering, and delivery across Pakistan.
